Status:
RECRUITING
High Flow Nasal Cannula in Pediatric Patients After Cardiothoracic Surgery
Lead Sponsor:
Osaka University
Collaborating Sponsors:
Osaka Women's and Children's Hospital
Hyogo Prefectural Kobe Children's Hospital
Conditions:
Pediatric Patients After Cardiothoracic Surgery
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
High flow nasal cannula(HFNC) ventilation can provide such effects as wash-out effect of the carbon dioxide inside the anatomical dead space,some level of continuous airway pressure and humidified oxy...
Detailed Description
The multi-center RCT will enroll 380 pediatric patients after cardiothoracic surgery from the Intensive Care Units (ICUs) in Japan.Informed consent will be obtained from the their parents or legally r...
Eligibility Criteria
Inclusion
- pediatric patients younger than two years old after cardiothoracic surgery
- pediatric patients who have been ventilated for more than 12 hours after surgery
Exclusion
- patients with tracheostomy
- patients with do-not-resuscitate (DNR)
- patients who have be treated by noninvasive positive pressure ventilation or high flow nasal cannula before surgery
- patients who undergo unplanned extubation
- patients who have withdrawn consent from their legal guardian
- patients who don't need oxygen therapy
- patients who are planned to receive treatment with noninvasive positive pressure ventilation after extubation
- patients who are planned to inhale nitric oxide(NO) after extubation
Key Trial Info
Start Date :
August 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT04451057
Start Date
August 11 2020
End Date
June 30 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Care Medicine, Osaka University
Osaka, Japan